🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Biliary and Pancreatic Diseases

A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 AB122 Platform Study NCT04999761Phase 19 sites📍 Aichi📍 Chiba📍 Ehime Taiho Pharmaceutical Co., Ltd. · Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy NCT06040801NA1 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Frailty intervention measures Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site📍 Mexico City Coordinación de Investigación en Salud, Mexico · Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experienced… A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis NCT04924868Phase 318 sites📍 Santiago de Compostela📍 Alicante📍 Elche Hospital General Universitario de Alicante · Tests: Ursodeoxycholic Acid, Placebo PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310Phase 11 site📍 Stockholm Karolinska University Hospital · Tests: 68Ga-FAPI-46, PET/CT A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989 Bile Omics for Diagnosing Indeterminate Biliary Strictures NCT07007832n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Endoscopic retrograde cholangiopancreatography Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors NCT04900818Phase 121 sites📍 Orange📍 Aurora📍 Layfayette I-Mab Biopharma US Limited · Tests: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (… Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis NCT06655051NA1 site📍 Shanghai Changhai Hospital · Tests: endoscopic retrograde biliary drainage (single plastic stent), endoscopic retrograde biliary drainage ( fully covered s… A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites📍 Denver📍 Orlando📍 Detroit BioNTech SE · Tests: BNT329, CA19-9-targeting monoclonal antibody Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy NCT06322680NA1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Main pancreatic duct and biliary duct external drainage, Main pancreatic duct and biliary duct internal drainage Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation NCT07335523n/a9 sites📍 Aurora📍 Washington D.C.📍 New York Digestive Care, Inc. · Tests: Fecal Fat A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347Phase 19 sites📍 Los Angeles📍 Sarasota📍 Tampa Kestrel Therapeutics, Inc. · Tests: KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab, Pembrolizumab, mFOLFOX6 Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572n/a1 site📍 Bethesda National Cancer Institute (NCI) In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers NCT07206355n/a1 site📍 Nottingham University of Nottingham Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska EUS Procedures Using RIVOS™ EUS Access Device NCT07696572n/a1 site📍 Orlando Orlando Health, Inc. · Tests: EUS-guided intervention using the RIVOS™ EUS access device A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) NCT06428409Phase 1, Phase 255 sites📍 Los Angeles📍 Aurora📍 Aurora Merck Sharp & Dohme LLC · Tests: Sacituzumab tirumotecan, Fluorouracil (5-FU), Leucovorin (LV) or levoleucovorin, Rescue medication, Supportive care mea… Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery NCT06731998NA1 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Local Anesthesia, Laparoscopic Transversus Abdominis Plane block Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection NCT05517811n/a2 sites📍 Aurora📍 Highlands Ranch University of Colorado, Denver · Tests: TEG indices CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors NCT06937567EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: CDH17 CAR-T, FAST LACO-Stim CDH17 CAR-T Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers NCT06139042n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Blood drawing Web-based International Register of Emergency Surgery and Trauma NCT03643718n/a1 site📍 Pisa A.O. Ospedale Papa Giovanni XXIII · Tests: Emergency General Surgery Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy NCT06065371Phase 11 site📍 Detroit Henry Ford Health System · Tests: Capecitabine, Sacituzumab govetican
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy